These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35429867)

  • 1. A highly sensitive spectrofluorimetric method for the determination of bilastine in its pharmaceutical preparations and biological fluids.
    Radwan AS; Elkhoudary MM; Hadad GM; Belal F; Salim MM
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Aug; 276():121246. PubMed ID: 35429867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly sensitive spectrofluorimetric method for the determination of bilastine in human plasma: Application of content uniformity testing.
    Omar MA; Khojah HMJ; Al Thagfan SS; Alolayan SO; Attia TZ
    Luminescence; 2024 Jul; 39(7):e4816. PubMed ID: 38965898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How bilastine is used to treat allergic rhinitis and urticaria in children.
    Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
    Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validated sensitive spectrofluorimetric method for determination of antihistaminic drug azelastine HCl in pure form and in pharmaceutical dosage forms: application to stability study.
    El-Masry AA; Hammouda ME; El-Wasseef DR; El-Ashry SM
    Luminescence; 2017 Mar; 32(2):177-181. PubMed ID: 27279096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    Demonte A; Guanti MB; Liberati S; Biffi A; Fernando F; Fainello M; Pepe P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):820-828. PubMed ID: 29461615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety profile of bilastine: 2nd generation H1-antihistamines.
    Scaglione F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.
    Wolthers OD
    Biomed Res Int; 2013; 2013():626837. PubMed ID: 23956994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effect of bilastine.
    Jauregizar N; de la Fuente L; Lucero ML; Sologuren A; Leal N; Rodríguez M
    Clin Pharmacokinet; 2009; 48(8):543-54. PubMed ID: 19705924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a green synchronous spectrofluorimetric technique for simultaneous determination of Montelukast sodium and Bilastine in pharmaceutical formulations.
    Derayea SM; Badr El-Din KM; Ahmed AS; Khorshed AA; Oraby M
    BMC Chem; 2024 Jan; 18(1):18. PubMed ID: 38268023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral availability of bilastine.
    Sádaba B; Gómez-Guiu A; Azanza JR; Ortega I; Valiente R
    Clin Drug Investig; 2013 May; 33(5):375-81. PubMed ID: 23529786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilastine: a new H
    Church MK; Labeaga L
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1447-1452. PubMed ID: 28467671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilastine: in allergic rhinitis and urticaria.
    Carter NJ
    Drugs; 2012 Jun; 72(9):1257-69. PubMed ID: 22686617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.
    Jáuregui I; García-Lirio E; Soriano AM; Gamboa PM; Antépara I
    Expert Rev Clin Immunol; 2012 Jan; 8(1):33-41. PubMed ID: 22149338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilastine for the relief of allergy symptoms.
    Sádaba Díaz de Rada B; Azanza Perea JR; Gomez-Guiu Hormigos A
    Drugs Today (Barc); 2011 Apr; 47(4):251-62. PubMed ID: 21573249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria.
    Rodríguez M; Vozmediano V; García-Bea A; Novák Z; Yáñez A; Campo C; Labeaga L
    Eur J Pediatr; 2020 May; 179(5):801-805. PubMed ID: 31919579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly sensitive micelle-enhanced synchronous spectrofluorimetric determination of the recently approved co-formulated drugs, bilastine and montelukast in pharmaceuticals and human plasma at nanogram levels.
    Magdy G; El Hamd MA; El-Maghrabey M; Zainy FM; Mahdi WA; Alshehri S; Alsaggaf WT; Radwan AS
    Luminescence; 2023 Dec; ():. PubMed ID: 38044037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers.
    Farré M; Pérez-Mañá C; Papaseit E; Menoyo E; Pérez M; Martin S; Bullich S; Rojas S; Herance JR; Trampal C; Labeaga L; Valiente R
    Br J Clin Pharmacol; 2014 Nov; 78(5):970-80. PubMed ID: 24833043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel spectrofluorimetric method for determination of imatinib in pure, pharmaceutical preparation, human plasma, and human urine.
    Zidan DW; Hassan WS; Elmasry MS; Shalaby AA
    Luminescence; 2018 Feb; 33(1):232-242. PubMed ID: 29094459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly sensitive spectrofluorimetric method for determination of doxazosin through derivatization with fluorescamine; Application to content uniformity testing.
    Omar MA; Hammad MA; Salman BI; Derayea SM
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Mar; 157():55-60. PubMed ID: 26716887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilastine: a lifetime companion for the treatment of allergies.
    Church MK; Tiongco-Recto M; Ridolo E; Novák Z
    Curr Med Res Opin; 2020 Mar; 36(3):445-454. PubMed ID: 31612732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.